Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950117-10-000244
Filing Date
2010-02-17
Accepted
2010-02-17 18:23:52
Documents
1
Period of Report
2010-02-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 rsr_17751.html 4  
1 FORM 4 rsr_17751.xml 4 2962
  Complete submission text file 0000950117-10-000244.txt   4825
Mailing Address 125 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140
Business Address 125 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140 617-349-4500
JAVELIN PHARMACEUTICALS, INC (Issuer) CIK: 0000050710 (see all company filings)

EIN.: 880471759 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O JAVELIN PHARMACEUTICALS, INC. 125 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address
Driscoll Martin J (Reporting) CIK: 0001339402 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32949 | Film No.: 10614237